Single Cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, PCR, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) & Region - Global Forecast to 2026
Instant Answers with GPT - Ask Now!
Ask real questions. Get complete answers !
Generating Response ...Updated on : April 28, 2023
The global Single Cell Analysis Market in terms of revenue was estimated to be worth $3.1 billion in 2021 and is poised to reach $6.3 billion by 2026, growing at a CAGR of 15.1% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth in this market is mainly driven by factors such as technological advancements in single-cell analysis products coupled with increasing R&D in the pharmaceutical and biotechnology industries, growing focus on personalized medicine, growth in stem cell research, and the rising prevalence of cancer. However, the high cost of single-cell analysis products is a major factor hampering the growth of the single-cell analysis market.
To know about the assumptions considered for the study, Request for Free Sample Report
Single Cell Analysis Market Dynamics
Driver: Growing prevalence of cancer
One of the most important application areas of single-cell analysis is cancer genomics. According to GLOBOCAN, the number of cancer cases will rise to approximately 30 million by 2040 from 19.3 million cases and 10 million cancer deaths in 2020. The growth in the prevalence of this disease has resulted in a need to conduct extensive research for diagnosis and treatment; single-cell analysis forms an important part of this research. The analysis of individual cells enables the correct diagnosis of diseases and monitoring of treatment efficacy. Single-cell analysis aids in the enumeration of helper T-cells, determination of DNA content, and monitoring the proliferation of tumor cells in breast cancer and other malignancies.
Restraint: High cost of single-cell analysis products
The cost of research in single-cell biology is high because of the need to maintain high-quality standards (the use of high-grade, expensive products) and comply with the guidelines set by regulatory authorities. However, research and academic laboratories find it difficult to afford such expensive instruments due to budget constraints. In addition, the maintenance costs and several other indirect expenses result in an overall increase in the total cost of ownership of these instruments. This is a major factor limiting the adoption of flow cytometers and microfluidic devices in both clinical and research applications.
Opportunity: High growth potential of single-cell sequencing
Single-cell sequencing is considered a powerful tool to identify disease-specific biomarkers to diagnose and monitor the occurrence and progress of a disease and the patient’s response to treatment. As the SCS technology provides extensive details pertaining to genetic mutations, companies are focusing on developing instruments and reagents that are suitable for single-cell sequencers. Considering the high-growth potential of this segment, several advanced SCS instruments are expected to be developed and launched in the market in the coming years.
The consumables segment dominated the single cell analysis market
Based on products, the market is segmented into consumables and instruments. Consumables accounted for the largest share of 67.4% of the single-cell analysis market. The large share of this segment can primarily be attributed to the frequent purchase of these products compared to instruments, which are considered a one-time investment. The wide applications of consumables in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are also expected to drive market growth.
The academic & research laboratories segment accounted for the largest share of the single cell analysis market
Based on end users, the market is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers. The academic & research laboratories segment accounted for the largest share of the single-cell analysis market. Factors such as growth in funding for life science research and the increasing number of medical colleges and universities are driving the growth of this end-user segment.
To know about the assumptions considered for the study, download the pdf brochure
North America was the largest regional market for single-cell analysis.
North America accounted for the largest share of 44.9% of the global single-cell analysis market. This market is expected to reach USD 2,520.2 million by 2026 from an estimated USD 1,282.2 million in 2021, at a CAGR of 14.5%. North America’s prominence in this market is mainly attributed to the presence of key market players, coupled with increasing R&D expenditure and federal funding.
The prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGAA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Illumina, Inc. (US), Fluidigm Corporation (US), 10X Genomics (US), and Corning Incorporated (US).
Single Cell Analysis Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$3.1 billion |
|
Projected Revenue by 2026 |
$6.3 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 15.1% |
|
Growth Driver |
Growing prevalence of cancer |
|
Growth Opportunity |
High growth potential of single-cell sequencing |
This report categorizes the single cell analysis market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Consumables
- Beads
- Microplates
- Reagents
-
Assay Kits
- Immunoassays
- Cell-based Assays
- Other Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials, Filtration Apparatus, Petri Dishes, Inserts, and Discs)
-
Instruments
- Flow Cytometers
- NGS Systems
- PCR Instruments
- Spectrophotometers
- Microscopes
- Cell Counters
- HCS Systems
- Microarrays
- Other Instruments
- Single Cell Analysis, by Cell Type
- Human Cells
- Animal Cells
- Microbial Cells
By Technique
- Flow Cytometry
- Next-generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Other Techniques
By Application
-
Research Applications
- Cancer
- Immunology
- Neurology
- Stem Cell
- Other Research Applications
-
Medical Applications
- Noninvasive Prenatal Diagnosis
- in Vitro Fertilization
- Circulating Tumor Cell Detection
By End Users
- Academic & Research Laboratories
- Biotechnology & Pharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Cell Banks & IVF Centers
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Spain
- Rest of Europe (RoE)
-
Asia Pacific (APAC)
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Latin America
- MEA
Recent Developments:
- In March 2021, Beckman Coulter (a subsidiary of Danaher Corporation) launched the CytoFLEX SRT Benchtop Sorter that features expanded laser and color options for use in labs of all sizes.
- In March 2020, Fluidigm Corporation (US) opened a new Center of Excellence (CoE) for Imaging Mass Cytometry (IMC) in Singapore, together with the Singapore Immunology Network (SIgN), part of the Agency for Science, Technology and Research..
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the single cell analysis market?
The single cell analysis market boasts a total revenue value of $6.3 billion by 2026.
What is the estimated growth rate (CAGR) of the single cell analysis market?
The global single cell analysis market has an estimated compound annual growth rate (CAGR) of 15.1% and a revenue size in the region of $3.1 billion in 2021.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 26)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARIES: SINGLE CELL ANALYSIS MARKET
2.2 MARKET DATA ESTIMATION & TRIANGULATION
FIGURE 4 DATA TRIANGULATION METHODOLOGY
2.3 MARKET ESTIMATION METHODOLOGY
FIGURE 5 MARKET SIZE ESTIMATION (APPROACH 1): SUPPLY-SIDE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION (APPROACH 2): SUPPLY-SIDE ANALYSIS
FIGURE 7 ILLUSTRATION OF REVENUE SHARE ANALYSIS
FIGURE 8 SINGLE-CELL ANALYSIS MARKET: FINAL MARKET SIZE (USD BILLION)
2.4 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 9 GROWTH RATE ASSUMPTION BASED ON MARKET DYNAMICS
FIGURE 10 FINAL CAGR PROJECTIONS (2021−2026)
2.5 INSIGHTS FROM PRIMARIES
FIGURE 11 MARKET VALIDATION FROM PRIMARY EXPERTS
2.6 RESEARCH ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT
3 EXECUTIVE SUMMARY (Page No. - 41)
FIGURE 12 SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 16 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 17 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 46)
4.1 SINGLE CELL ANALYSIS MARKET OVERVIEW
FIGURE 18 TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS TO SUPPORT MARKET GROWTH
4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SHARE, BY PRODUCT & COUNTRY (2020)
FIGURE 19 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2020
4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 20 CONSUMABLES WILL CONTINUE TO DOMINATE THE SINGLE-CELL ANALYSIS MARKET IN 2026
4.4 SINGLE-CELL ANALYSIS MARKET SHARE, BY END USER, 2020
FIGURE 21 ACADEMIC & RESEARCH LABORATORIES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.5 SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 22 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE SINGLE-CELL ANALYSIS MARKET FROM 2021 TO 2026
5 MARKET OVERVIEW (Page No. - 49)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 SINGLE CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in single-cell analysis products
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES
5.2.1.2 Rising prevalence of cancer
TABLE 4 PROJECTED INCREASE IN THE NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
5.2.1.3 Increasing R&D in the pharmaceutical & biotechnology industries for complex diseases
FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.4 Growth in stem cell research
5.2.1.5 Growing focus on personalized medicine
5.2.2 RESTRAINTS
5.2.2.1 High cost of single-cell analysis products
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of single-cell sequencing
5.2.3.2 Integration of microfluidics in single-cell analysis
5.2.3.3 Emerging Asian markets
5.3 RANGES/SCENARIO
FIGURE 25 SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE SINGLE-CELL ANALYSIS MARKET
5.4 IMPACT OF COVID-19 ON THE SINGLE-CELL ANALYSIS MARKET
FIGURE 26 SINGLE-CELL ANALYSIS MARKET SCENARIO: PRE- AND POST-COVID-19 IMPACT, 2019–2021
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 REVENUE SHIFT & NEW POCKETS FOR SINGLE-CELL ANALYSIS PROVIDERS
5.6 PRICING ANALYSIS
TABLE 5 PRICE OF SINGLE-CELL ANALYSIS PRODUCTS (2020)
TABLE 6 AVERAGE SELLING PRICE OF NGS SYSTEMS (2020)
5.7 VALUE CHAIN ANALYSIS
FIGURE 28 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 29 SUPPLY CHAIN ANALYSIS OF THE SINGLE-CELL ANALYSIS MARKET
5.9 ECOSYSTEM ANALYSIS
FIGURE 30 ECOSYSTEM ANALYSIS: SINGLE-CELL ANALYSIS MARKET
TABLE 7 SUPPLY CHAIN ECOSYSTEM
5.10 TECHNOLOGY ANALYSIS
TABLE 8 COMPARISON OF SINGLE-CELL ANALYSIS TECHNOLOGIES
5.11 PATENT ANALYSIS
FIGURE 31 PATENTS GRANTED IN THE SINGLE-CELL ANALYSIS MARKET IN THE LAST 10 YEARS
TABLE 9 INDICATIVE LIST OF PATENTS IN THE SINGLE-CELL ANALYSIS MARKET
5.12 REGULATORY ANALYSIS
TABLE 10 REGULATORY SCENARIO
5.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.13.1 THREAT FROM NEW ENTRANTS
5.13.2 THREAT FROM SUBSTITUTES
5.13.3 BARGAINING POWER OF BUYERS
5.13.4 BARGAINING POWER OF SUPPLIERS
5.13.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
6 SINGLE CELL ANALYSIS MARKET, BY PRODUCT (Page No. - 71)
6.1 INTRODUCTION
TABLE 12 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 13 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 BEADS
6.2.1.1 Wide application of beads in the isolation of RNA and DNA to drive market growth
TABLE 14 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2 MICROPLATES
6.2.2.1 Increasing demand for genomic technologies will boost the market for microplates in the coming years
TABLE 15 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3 REAGENTS
6.2.3.1 Advancements in single-cell genomics are likely to increase the adoption of reagents
TABLE 16 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.4 ASSAY KITS
TABLE 17 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 18 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.4.1 Immunoassays
6.2.4.1.1 Innovations in immunoassays to drive the growth of this segment
TABLE 19 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.4.2 Cell-based assays
6.2.4.2.1 Rising R&D activities in pharma and biopharma companies will drive the demand for cell-based assays
TABLE 20 SINGLE-CELL ANALYSIS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.5 OTHER CONSUMABLES
TABLE 21 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 22 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 23 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1 FLOW CYTOMETERS
6.3.1.1 Technological advancements in flow cytometry to drive the growth of this segment
TABLE 24 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2 NGS SYSTEMS
6.3.2.1 Advancements in NGS systems to support the market growth
TABLE 25 SINGLE-CELL ANALYSIS MARKET FOR NGS SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.3 PCR INSTRUMENTS
6.3.3.1 Usage of PCR to amplify DNA and mRNA from single cells to study gene expression is expected to boost the market
TABLE 26 SINGLE-CELL ANALYSIS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.4 SPECTROPHOTOMETERS
6.3.4.1 Spectrophotometers play an integral role in the life science industry
TABLE 27 SINGLE-CELL ANALYSIS MARKET FOR SPECTROPHOTOMETERS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.5 MICROSCOPES
6.3.5.1 Wide applications in cell-based research to drive the adoption of microscopes
TABLE 28 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPES, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.6 CELL COUNTERS
6.3.6.1 Reliable and quick results associated with cell counters are supporting the growth of this market segment
TABLE 29 SINGLE-CELL ANALYSIS MARKET FOR CELL COUNTERS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.7 HCS SYSTEMS
6.3.7.1 Increasing need for multi-parametric cell analysis to drive the adoption of HCS systems
TABLE 30 SINGLE-CELL ANALYSIS MARKET FOR HCS SYSTEMS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.8 MICROARRAYS
6.3.8.1 Increasing demand for microarrays in the field of molecular biology to support market growth
TABLE 31 SINGLE-CELL ANALYSIS MARKET FOR MICROARRAYS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.9 OTHER INSTRUMENTS
TABLE 32 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019–2026 (USD MILLION)
7 SINGLE CELL ANALYSIS MARKET, BY CELL TYPE (Page No. - 93)
7.1 INTRODUCTION
TABLE 33 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
7.2 HUMAN CELLS
7.2.1 INCREASING CANCER RESEARCH & FUNDING TO PROPEL MARKET GROWTH
TABLE 34 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2019–2026 (USD MILLION)
7.3 ANIMAL CELLS
7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET GROWTH
TABLE 35 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2019–2026 (USD MILLION)
7.4 MICROBIAL CELLS
7.4.1 RISING GOVERNMENT SUPPORT TO DETECT & COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET GROWTH
TABLE 36 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2019–2026 (USD MILLION)
8 SINGLE CELL ANALYSIS MARKET, BY TECHNIQUE (Page No. - 99)
8.1 INTRODUCTION
TABLE 37 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
8.2 FLOW CYTOMETRY
8.2.1 WIDE USAGE OF FLOW CYTOMETRY TO STUDY CELL MORPHOLOGIES AND IDENTIFY CANCEROUS CELLS TO DRIVE MARKET GROWTH
TABLE 38 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2019–2026 (USD MILLION)
8.3 NEXT-GENERATION SEQUENCING
8.3.1 NGS IS THE FASTEST-GROWING SEGMENT IN THE SINGLE-CELL ANALYSIS MARKET
TABLE 39 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2019–2026 (USD MILLION)
8.4 POLYMERASE CHAIN REACTION
8.4.1 LATEST ADVANCEMENTS IN PCR TECHNIQUES TO SUPPORT MARKET GROWTH
TABLE 40 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2019–2026 (USD MILLION)
8.5 MICROSCOPY
8.5.1 INCREASING INVESTMENTS IN CELL BIOLOGY RESEARCH TO PROPEL MARKET GROWTH
TABLE 41 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2019–2026 (USD MILLION)
8.6 MASS SPECTROMETRY
8.6.1 LAUNCH OF NEW AND ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 42 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2019–2026 (USD MILLION)
8.7 OTHER TECHNIQUES
TABLE 43 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2019–2026 (USD MILLION)
9 SINGLE CELL ANALYSIS MARKET, BY APPLICATION (Page No. - 108)
9.1 INTRODUCTION
TABLE 44 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
9.2 RESEARCH APPLICATIONS
FIGURE 32 INCREASING NUMBER OF CLINICAL TRIALS REGISTERED WORLDWIDE (2000–2021)
TABLE 45 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 46 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
9.2.1 CANCER RESEARCH
9.2.1.1 Growing prevalence of cancer to support market growth
TABLE 47 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2019–2026 (USD MILLION)
9.2.2 IMMUNOLOGY RESEARCH
9.2.2.1 High incidence of infectious diseases and growing demand for advanced vaccines to propel market growth
TABLE 48 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2019–2026 (USD MILLION)
9.2.3 NEUROLOGY RESEARCH
9.2.3.1 Increasing incidence of neurological disorders to boost the market growth
TABLE 49 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2019–2026 (USD MILLION)
9.2.4 STEM CELL RESEARCH
9.2.4.1 Rising investments in stem cell research to drive the growth of this application segment
TABLE 50 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2019–2026 (USD MILLION)
9.2.5 OTHER RESEARCH APPLICATIONS
TABLE 51 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
9.3 MEDICAL APPLICATIONS
TABLE 52 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
9.3.1 NON-INVASIVE PRENATAL DIAGNOSIS
9.3.1.1 Rising prevalence of genetic diseases to drive market growth
TABLE 53 SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2019–2026 (USD MILLION)
9.3.2 IN VITRO FERTILIZATION
9.3.2.1 Increasing demand for in vitro fertilization procedures to support the growth of this application segment
TABLE 54 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2019–2026 (USD MILLION)
9.3.3 CIRCULATING TUMOR CELL DETECTION
9.3.3.1 Rising prevalence of cancer to contribute to the growth of this segment
TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2019–2026 (USD MILLION)
10 SINGLE CELL ANALYSIS MARKET, BY END USER (Page No. - 122)
10.1 INTRODUCTION
TABLE 56 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2 ACADEMIC & RESEARCH LABORATORIES
10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE GROWTH IN THIS END-USER SEGMENT
TABLE 57 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO SUPPORT MARKET GROWTH
TABLE 58 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
10.4 HOSPITALS & DIAGNOSTIC LABORATORIES
10.4.1 HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES TO DRIVE THE ADOPTION OF SINGLE-CELL ANALYSIS PRODUCTS AMONG HOSPITALS & DIAGNOSTIC LABS
TABLE 59 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
10.5 CELL BANKS & IVF CENTERS
10.5.1 RISING DEMAND FOR PERSONALIZED & REGENERATIVE MEDICINE TO SUPPORT MARKET GROWTH
TABLE 60 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
11 SINGLE CELL ANALYSIS MARKET, BY REGION (Page No. - 130)
11.1 INTRODUCTION
TABLE 61 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2019–2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: SINGLE CELL ANALYSIS MARKET SNAPSHOT
TABLE 62 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 NORTH AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 69 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.1 US
11.2.1.1 Increasing R&D investments and funding to drive market growth in the US
FIGURE 34 NIH FUNDING IN THE LAST 10 YEARS (2011–2021)
TABLE 73 US: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 74 US: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 US: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 78 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 79 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 80 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 High prevalence of hemophilia to drive market growth in Canada
TABLE 83 CANADA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 84 CANADA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 CANADA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 88 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 89 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 90 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3 EUROPE
TABLE 93 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 94 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 95 EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 99 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 100 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 101 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Government support for research funding to support the growth of the single cell analysis market in the country
TABLE 104 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 105 GERMANY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 107 GERMANY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 109 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 110 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 111 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2 UK
11.3.2.1 Growing adoption of single-cell analysis products, coupled with favorable research conditions, to drive market growth in the UK
TABLE 114 UK: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 115 UK: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 UK: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 119 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 120 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 121 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Growing government initiatives to boost R&D in the country to propel the adoption of single-cell analysis products
TABLE 124 FRANCE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 125 FRANCE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 FRANCE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 128 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 129 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 130 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 131 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Advancements in biotechnology and increasing R&D investments by pharmaceutical companies to drive the market for single-cell analysis in Italy
TABLE 134 ITALY: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 135 ITALY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 ITALY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 139 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 140 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 141 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Strong R&D infrastructure and growing focus on cancer research to support market growth in Spain
TABLE 144 SPAIN: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 145 SPAIN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 SPAIN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 149 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 150 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 151 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 154 ROE: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 155 ROE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 156 ROE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 ROE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 ROE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 159 ROE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 160 ROE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 161 ROE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 162 ROE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 163 ROE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 164 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 166 ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 167 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 168 ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 170 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 171 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 172 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 174 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Rising geriatric population and growing focus on personalized medicine to propel market growth in Japan
TABLE 175 JAPAN: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
TABLE 176 JAPAN: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 177 JAPAN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 JAPAN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 181 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 182 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 183 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 185 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Growing stem cell research and the high incidence of chronic diseases to drive market growth in China
TABLE 186 CHINA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 187 CHINA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 188 CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 189 CHINA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 191 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 192 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 193 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 194 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 195 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Increasing government support for stem cell-based therapies and expansion of the pharmaceutical and biotechnology industries in India to support market growth
TABLE 196 INDIA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 197 INDIA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 198 INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 199 INDIA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 201 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 202 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 203 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 204 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 205 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 206 ROAPAC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 207 ROAPAC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 208 ROAPAC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 209 ROAPAC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 211 ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 212 ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 213 ROAPAC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 214 ROAPAC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 ROAPAC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 EXPANSION OF THE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES TO DRIVE MARKET GROWTH IN LATAM
TABLE 216 LATIN AMERICA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 217 LATIN AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 218 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 219 LATIN AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 220 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 221 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 222 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 223 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 224 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 225 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST & AFRICA
TABLE 226 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 227 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 228 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 229 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 230 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
TABLE 231 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION)
TABLE 232 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 233 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 234 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 235 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 205)
12.1 INTRODUCTION
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 36 SINGLE CELL ANALYSIS MARKET: STRATEGIES ADOPTED
12.3 REVENUE ANALYSIS
FIGURE 37 REVENUE ANALYSIS FOR KEY COMPANIES OVER THE PAST THREE YEARS
12.4 MARKET SHARE ANALYSIS
FIGURE 38 MARKET SHARE, BY KEY PLAYER (2020)
12.5 COMPANY EVALUATION QUADRANT
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 39 MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
12.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
FIGURE 40 SINGLE CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2020
12.7 COMPETITIVE BENCHMARKING
12.7.1 COMPANY FOOTPRINT (20 COMPANIES)
FIGURE 41 FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-CELL ANALYSIS MARKET
12.7.2 COMPANY PRODUCT FOOTPRINT (20 COMPANIES)
TABLE 236 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-CELL ANALYSIS MARKET
12.7.3 COMPANY REGIONAL FOOTPRINT (20 COMPANIES)
TABLE 237 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE SINGLE-CELL ANALYSIS MARKET
12.8 COMPETITIVE SCENARIO AND TRENDS
12.8.1 PRODUCT LAUNCHES
TABLE 238 SINGLE CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2018–JULY 2021
12.8.2 DEALS
TABLE 239 MARKET: DEALS, JANUARY 2018–JULY 2021
12.8.3 OTHER DEVELOPMENTS
TABLE 240 SINGLE CELL ANALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2018–JULY 2021
13 COMPANY PROFILES (Page No. - 219)
(Business overview, Products offered, Recent developments & MnM View)*
13.1 KEY COMPANIES
13.1.1 BECTON, DICKINSON AND COMPANY
TABLE 241 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
13.1.2 DANAHER CORPORATION
TABLE 242 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
13.1.3 MERCK KGAA
TABLE 243 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2020)
13.1.4 THERMO FISHER SCIENTIFIC, INC.
TABLE 244 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 45 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
13.1.5 QIAGEN N.V.
TABLE 245 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 46 QIAGEN N.V.: COMPANY SNAPSHOT (2020)
13.1.6 10X GENOMICS
TABLE 246 10X GENOMICS: BUSINESS OVERVIEW
FIGURE 47 10X GENOMICS: COMPANY SNAPSHOT (2020)
13.1.7 PROMEGA CORPORATION
TABLE 247 PROMEGA CORPORATION: BUSINESS OVERVIEW
13.1.8 ILLUMINA
TABLE 248 ILLUMINA: BUSINESS OVERVIEW
FIGURE 48 ILLUMINA: COMPANY SNAPSHOT (2020)
13.1.9 BIO-RAD LABORATORIES
TABLE 249 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 49 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)
13.1.10 FLUIDIGM CORPORATION
TABLE 250 FLUIDIGM CORPORATION: BUSINESS OVERVIEW
FIGURE 50 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2020)
13.1.11 AGILENT TECHNOLOGIES, INC.
TABLE 251 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
13.1.12 CORNING INCORPORATED
TABLE 252 CORNING INCORPORATED: BUSINESS OVERVIEW
FIGURE 52 CORNING INCORPORATED: COMPANY SNAPSHOT (2020)
13.1.13 TAKARA BIO INC.
TABLE 253 TAKARA BIO INC.: BUSINESS OVERVIEW
FIGURE 53 TAKARA BIO INC.: COMPANY SNAPSHOT (2020)
13.1.14 BIOMÉRIEUX SA
TABLE 254 BIOMÉRIEUX SA.: BUSINESS OVERVIEW
FIGURE 54 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
13.1.15 TECAN GROUP LTD.
TABLE 255 TECAN GROUP LTD.: BUSINESS OVERVIEW
FIGURE 55 TECAN GROUP LTD.: COMPANY SNAPSHOT (2020)
13.1.16 SARTORIUS AG
TABLE 256 SARTORIUS AG.: BUSINESS OVERVIEW
FIGURE 56 SARTORIUS AG: COMPANY SNAPSHOT (2020)
13.1.17 LUMINEX CORPORATION
TABLE 257 LUMINEX CORPORATION: BUSINESS OVERVIEW
FIGURE 57 LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS
13.2.1 OXFORD NANOPORE TECHNOLOGIES
13.2.2 CYTEK BIOSCIENCES
13.2.3 FLUXION BIOSCIENCES
13.2.4 MENARINI SILICON BIOSYSTEMS
13.2.5 APOGEE FLOW SYSTEMS LTD.
13.2.6 NANOCELLECT BIOMEDICAL
13.2.7 ON-CHIP BIOTECHNOLOGIES CO., LTD.
13.2.8 RARECYTE, INC.
14 APPENDIX (Page No. - 290)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the single cell analysis market. Exhaustive secondary research was carried out to collect information on the market and its peer markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell analysis market. Some of the key secondary sources referred to for this study include publications from government sources World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), Organisation for Economic Co-operation and Development (OECD), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC). These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Supply-side analysis approach was used to estimate and validate the total size of the single cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the single cell analysis business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the single cell analysis market based on cell type, product, technique, application, end users and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints & opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single cell analysis market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the single cell analysis market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Company Information
- An additional five company profiles
Growth opportunities and latent adjacency in Single Cell Analysis Market